ArticleThe New England journal of medicine2021

Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.

Junne Kamihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.